Hyperthermic Intraperitoneal Chemotherapy (HIPEC) treatment is reshaping the way doctors fight advanced abdominal cancers.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) treatment is reshaping the way doctors fight advanced abdominal cancers.
Pfizer publishes on successful use of EpiSwitch biomarkers evaluating tumour status and treatment outcomes from the JAVELIN Bladder 100 Trial